The NordiNet® International Outcome Study and NovoNet® ANSWER Program®: rationale, design, and methodology of two international pharmacoepidemiological registry-based studies monitoring long-term clinical and safety outcomes of growth hormone therapy (Norditropin®)

OBJECTIVE: Randomized controlled trials have shown that growth hormone (GH) therapy has effects on growth, metabolism, and body composition. GH therapy is prescribed for children with growth failure and adults with GH deficiency. Carefully conducted observational study of GH treatment affords the op...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Höybye, Charlotte, Sävendahl, Lars, Christesen, Henrik Thybo, Lee, Peter, Pedersen, Birgitte Tønnes, Schlumpf, Michael, Germak, John, Ross, Judith
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2013
Teme:
Review
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3641810/
https://ncbi.nlm.nih.gov/pubmed/23658497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CLEP.S42602
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items